NSD2通过其PHD域聚集至致癌基因位点以诱发多发性骨髓瘤
Abstract
Histone lysine methyltransferase NSD2 (WHSC1/MMSET) is overexpressed frequently in multiple myeloma due to the t(4;14) translocation associated with 15% to 20% of cases of this disease. NSD2 has been found to be involved in myelomagenesis, suggesting it may offer a novel therapeutic target. Here we show that NSD2 methyltransferase activity is crucial for clonogenicity, adherence, and proliferation of multiple myeloma cells on bone marrow stroma in vitro and that NSD2 is required for tumorigenesis of t(4;14)+ but not t(4;14)-multiple myeloma cells in vivo. The PHD domains in NSD2 were important for its cellular activity and biological function through recruiting NSD2 to its oncogenic target genes and driving their transcriptional activation. By strengthening its disease linkage and deepening insights into its mechanism of action, this study provides a strategy to therapeutically target NSD2 in multiple myeloma patients with a t(4;14) translocation.
上一篇: 【先天性心脏病】右心室发育中等的室隔完整型肺动脉闭锁同期行肺动脉瓣射频打孔及动脉导管支架置入:早期及中期随访结果
下一篇: GPR116: 一种G蛋白偶联受体——可通过Gαq-p63 Rho GEF-Rho GTP酶通路促进乳腺癌转移
来源: Scopus
- 您可能感兴趣的文章
-